Doc Mercer
EOG Master
U.S.: Drug Profiteering, Bird Flu and Navajo Hantavirus, by Brenda Norrell (censored by Indian Country Today)
U.N. OBSERVER & International Report
<table border="0" cellpadding="0" cellspacing="0" width="585"><tbody><tr><td valign="top" width="500"> While states prepare for the possibility of Avian or bird flu pandemic, corporate analysts question if the bird flu scare was a hoax designed to benefit Defense Secretary Donald Rumsfeld and the companies manufacturing the antiviral drug Tamiflu.
Rumsfeld?s rise in wealth from the sales of Tamiflu was recently revealed and resulted in questions about the pandemic scare.
Fortune magazine reported that after the bird flu scare, stocks rose and Rumsfeld, already one of the richest men in the Bush cabinet, benefited by at least $1 million in 2005, with profits continuing.
Tamiflu is manufactured and marketed by Swiss pharmaceutical giant Roche. Gilead Sciences, Inc. receives a royalty of about 10 percent from sales.
Rumsfeld served as chairman of Gilead Sciences, Inc., before joining the Bush administration. Rumsfeld still holds between $5 million and $25 million in the company, according to Rumsfeld?s financial disclosures.
http://bsnorrell.tripod.com/id73.html
</td></tr></tbody></table>
U.N. OBSERVER & International Report
<table border="0" cellpadding="0" cellspacing="0" width="585"><tbody><tr><td valign="top" width="500"> While states prepare for the possibility of Avian or bird flu pandemic, corporate analysts question if the bird flu scare was a hoax designed to benefit Defense Secretary Donald Rumsfeld and the companies manufacturing the antiviral drug Tamiflu.
Rumsfeld?s rise in wealth from the sales of Tamiflu was recently revealed and resulted in questions about the pandemic scare.
Fortune magazine reported that after the bird flu scare, stocks rose and Rumsfeld, already one of the richest men in the Bush cabinet, benefited by at least $1 million in 2005, with profits continuing.
Tamiflu is manufactured and marketed by Swiss pharmaceutical giant Roche. Gilead Sciences, Inc. receives a royalty of about 10 percent from sales.
Rumsfeld served as chairman of Gilead Sciences, Inc., before joining the Bush administration. Rumsfeld still holds between $5 million and $25 million in the company, according to Rumsfeld?s financial disclosures.
http://bsnorrell.tripod.com/id73.html
</td></tr></tbody></table>